Signal mining and analysis of ripretinib adverse events: a real-world pharmacovigilance analysis based on the FAERS database
This study identified some known AEs associated with ripretinib and discovered unexpected AEs, providing preliminary insights into its safety in the real world. This information is valuable for clinical monitoring and the safe use of ripretinib.
Authors
- Cunlin Yin
- Qiang Gong (ORCID: https://orcid.org/0000-0001-8502-6813)
- Hui Wu (ORCID: https://orcid.org/0000-0002-1620-5321)
- Yang Miao (ORCID: https://orcid.org/0000-0002-4127-2980)
- Linlin Zhang (ORCID: https://orcid.org/0000-0003-2605-6611)
- Lei Huang (ORCID: https://orcid.org/0000-0001-6770-6399)
- Ye Hu
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Yancheng First People's Hospital (CN)
- Second Affiliated Hospital of Nantong University
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-26
- DOI
- https://doi.org/10.3389/fphar.2025.1481114
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00